Credit Agricole’s GSK GSK Stock Holding History

Credit Agricole’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-51,680	Closed	-$2.8M	–	1631
2016 Q2	$2.8M	Buy	+51,680	New	+$2.72M	0.01%	759

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Credit Agricole's GSK Position: Q1 2026 in Review

Credit Agricole reduced its GSK (GSK) stake by 11% in Q1 2026, selling an estimated $775K and leaving 114,180 shares worth $6.3M. The position accounts for 0.02% of the portfolio, ranked #516.

Credit Agricole first reported a position in GSK in Q4 2014 and has held it in 29 quarters since. 1,032 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

Credit Agricole held 114,180 shares of GSK worth $6.3M as of Q1 2026.
Credit Agricole sold 14,297 GSK shares in Q1 2026, an estimated $775K.
GSK made up 0.02% of Credit Agricole's portfolio in Q1 2026, its #516 holding.
Credit Agricole first reported a position in GSK in Q4 2014 and has held it in 29 quarters since.
1,032 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Credit Agricole's 13F filing for Q1 2026, filed 15 May 2026.